Efficacy of ongoing group based diabetes self-management education for patients with type 2 diabetes mellitus. A randomised controlled trial

2012 ◽  
Vol 86 (1) ◽  
pp. 98-105 ◽  
Author(s):  
Lisbeth Ø. Rygg ◽  
Marit By Rise ◽  
Kjersti Grønning ◽  
Aslak Steinsbekk
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Randomised Controlled Trial ◽  
Management Education ◽  
Controlled Trial ◽  
Self Management ◽  
Randomised Controlled

Efficacy of a self-management education programme on patients with type 2 diabetes in primary care: A randomised controlled trial

2019 ◽  
Vol 13 (2) ◽  
pp. 122-133 ◽  
Author(s):  
Estibaliz Gamboa Moreno ◽  
Maider Mateo-Abad ◽  
Lourdes Ochoa de Retana García ◽  
Kalliopi Vrotsou ◽  
Emma del Campo Pena ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Primary Care ◽  
Randomised Controlled Trial ◽  
Management Education ◽  
Controlled Trial ◽  
Education Programme ◽  
Self Management ◽  
Randomised Controlled

scholarly journals Qatar Diabetes Mobile Application Trial (QDMAT): An Open-Label Randomised Controlled Trial To Examine The Impact of Using A Mobile Application To Improve Diabetes Care In Type 2 Diabetes Mellitus – A Study Protocol

2021 ◽  
Author(s):  
Noor Suleiman ◽  
Meis Alkasem ◽  
Zaina Al Amer ◽  
Obada Salameh ◽  
Noora Al-Thani ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Mobile Application ◽  
Primary Outcome ◽  
Controlled Trial ◽  
Self Management ◽  
Open Label ◽  
Randomised Controlled

Abstract BackgroundMobile health (mHealth) is increasingly advocated for diabetes management. It is unclear if mobile applications are effective in improving glycaemic control, clinical outcomes, quality of life and overall patient satisfaction in patients with diabetes. A new mobile application was specifically built for people with diabetes with the help of the local expertise. The objective of the study was to evaluate the effectiveness of the mobile App.MethodsThe planned study is an ongoing open-label randomised controlled trial in which insulin-treated adults with type 2 diabetes mellitus (T2DM) will be randomised 1:1 to the use of this diabetes application versus current standard care. The primary outcome will be the difference in mean HbA1c from baseline at 6 months. Other outcome measures include anthropometric measures, hypoglycaemic events, medication adjustments, number of clinical interactions and missed appointments, and patient perceptions of their disease and diabetes self-management. The study will randomise 180 subjects ( for assessment of the primary outcome. DiscussionWe hypothesise that the diabetes-specific mobile application will improve glycaemic control, increase patient empowerment for self-management of diabetes and improve interaction between patients and healthcare providers. If QDMAT demonstrates this, it will inform clinical services for the future self-management of T2DM.Trial Registration,ClinicalTrials.gov Identifier: NCT03998267) Registered on 26 June 2019

Food label education does not reduce sodium intake in people with type 2 diabetes mellitus. A randomised controlled trial

Appetite ◽  
2013 ◽  
Vol 68 ◽  
pp. 147-151 ◽  
Author(s):  
Kristina S. Petersen ◽  
David J. Torpy ◽  
Ian M. Chapman ◽  
Sanghamitra Guha ◽  
Peter M. Clifton ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Randomised Controlled Trial ◽  
Sodium Intake ◽  
Controlled Trial ◽  
Food Label ◽  
Reduce Sodium Intake ◽  
Randomised Controlled
Sign in / Sign up

Export Citation Format

Share Document